Table of Content

1 Anti-Tuberculosis Drug Market Overview
1.1 Product Overview and Scope of Anti-Tuberculosis Drug
1.2 Anti-Tuberculosis Drug Segment by Type
1.2.1 Global Anti-Tuberculosis Drug Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 First-Line Anti-Tuberculosis Drugs
1.2.3 Second-Line Anti-Tuberculosis Drugs
1.3 Anti-Tuberculosis Drug Segment by Application
1.3.1 Anti-Tuberculosis Drug Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Anti-Tuberculosis Drug Market Size Estimates and Forecasts
1.4.1 Global Anti-Tuberculosis Drug Revenue 2016-2027
1.4.2 Global Anti-Tuberculosis Drug Sales 2016-2027
1.4.3 Anti-Tuberculosis Drug Market Size by Region: 2016 Versus 2021 Versus 2027

2 Anti-Tuberculosis Drug Market Competition by Manufacturers
2.1 Global Anti-Tuberculosis Drug Sales Market Share by Manufacturers (2016-2021)
2.2 Global Anti-Tuberculosis Drug Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Anti-Tuberculosis Drug Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Anti-Tuberculosis Drug Manufacturing Sites, Area Served, Product Type
2.5 Anti-Tuberculosis Drug Market Competitive Situation and Trends
2.5.1 Anti-Tuberculosis Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Anti-Tuberculosis Drug Players Market Share by Revenue
2.5.3 Global Anti-Tuberculosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Anti-Tuberculosis Drug Retrospective Market Scenario by Region
3.1 Global Anti-Tuberculosis Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Anti-Tuberculosis Drug Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Anti-Tuberculosis Drug Market Facts & Figures by Country
3.3.1 North America Anti-Tuberculosis Drug Sales by Country
3.3.2 North America Anti-Tuberculosis Drug Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Anti-Tuberculosis Drug Market Facts & Figures by Country
3.4.1 Europe Anti-Tuberculosis Drug Sales by Country
3.4.2 Europe Anti-Tuberculosis Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 UK
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Anti-Tuberculosis Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Anti-Tuberculosis Drug Sales by Region
3.5.2 Asia Pacific Anti-Tuberculosis Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Anti-Tuberculosis Drug Market Facts & Figures by Country
3.6.1 Latin America Anti-Tuberculosis Drug Sales by Country
3.6.2 Latin America Anti-Tuberculosis Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Anti-Tuberculosis Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Anti-Tuberculosis Drug Sales by Country
3.7.2 Middle East and Africa Anti-Tuberculosis Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Anti-Tuberculosis Drug Historic Market Analysis by Type
4.1 Global Anti-Tuberculosis Drug Sales Market Share by Type (2016-2021)
4.2 Global Anti-Tuberculosis Drug Revenue Market Share by Type (2016-2021)
4.3 Global Anti-Tuberculosis Drug Price by Type (2016-2021)

5 Global Anti-Tuberculosis Drug Historic Market Analysis by Application
5.1 Global Anti-Tuberculosis Drug Sales Market Share by Application (2016-2021)
5.2 Global Anti-Tuberculosis Drug Revenue Market Share by Application (2016-2021)
5.3 Global Anti-Tuberculosis Drug Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Lupin
6.1.1 Lupin Corporation Information
6.1.2 Lupin Description and Business Overview
6.1.3 Lupin Anti-Tuberculosis Drug Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Lupin Product Portfolio
6.1.5 Lupin Recent Developments/Updates
6.2 Otsuka
6.2.1 Otsuka Corporation Information
6.2.2 Otsuka Description and Business Overview
6.2.3 Otsuka Anti-Tuberculosis Drug Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Otsuka Product Portfolio
6.2.5 Otsuka Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Anti-Tuberculosis Drug Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Sanofi Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Prizer
6.4.1 Prizer Corporation Information
6.4.2 Prizer Description and Business Overview
6.4.3 Prizer Anti-Tuberculosis Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Prizer Product Portfolio
6.4.5 Prizer Recent Developments/Updates
6.5 Abbott
6.5.1 Abbott Corporation Information
6.5.2 Abbott Description and Business Overview
6.5.3 Abbott Anti-Tuberculosis Drug Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Abbott Product Portfolio
6.5.5 Abbott Recent Developments/Updates
6.6 NOVARTIS
6.6.1 NOVARTIS Corporation Information
6.6.2 NOVARTIS Description and Business Overview
6.6.3 NOVARTIS Anti-Tuberculosis Drug Sales, Revenue and Gross Margin (2016-2021)
6.6.4 NOVARTIS Product Portfolio
6.6.5 NOVARTIS Recent Developments/Updates

7 Anti-Tuberculosis Drug Manufacturing Cost Analysis
7.1 Anti-Tuberculosis Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Anti-Tuberculosis Drug
7.4 Anti-Tuberculosis Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Anti-Tuberculosis Drug Distributors List
8.3 Anti-Tuberculosis Drug Customers

9 Anti-Tuberculosis Drug Market Dynamics
9.1 Anti-Tuberculosis Drug Industry Trends
9.2 Anti-Tuberculosis Drug Growth Drivers
9.3 Anti-Tuberculosis Drug Market Challenges
9.4 Anti-Tuberculosis Drug Market Restraints

10 Global Market Forecast
10.1 Anti-Tuberculosis Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Anti-Tuberculosis Drug by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Anti-Tuberculosis Drug by Type (2022-2027)
10.2 Anti-Tuberculosis Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Anti-Tuberculosis Drug by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Anti-Tuberculosis Drug by Application (2022-2027)
10.3 Anti-Tuberculosis Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Anti-Tuberculosis Drug by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Anti-Tuberculosis Drug by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Anti-Tuberculosis Drug Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Anti-Tuberculosis Drug Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Anti-Tuberculosis Drug Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Anti-Tuberculosis Drug Covered in This Study
Table 5. Global Anti-Tuberculosis Drug Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Anti-Tuberculosis Drug Sales Share by Manufacturers (2016-2021)
Table 7. Global Anti-Tuberculosis Drug Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Anti-Tuberculosis Drug Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Anti-Tuberculosis Drug Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Anti-Tuberculosis Drug Manufacturing Sites and Area Served
Table 11. Manufacturers Anti-Tuberculosis Drug Product Type
Table 12. Global Anti-Tuberculosis Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Anti-Tuberculosis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Tuberculosis Drug as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Anti-Tuberculosis Drug Sales by Region (2016-2021) & (K Units)
Table 16. Global Anti-Tuberculosis Drug Sales Market Share by Region (2016-2021)
Table 17. Global Anti-Tuberculosis Drug Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Anti-Tuberculosis Drug Sales by Country (2016-2021) & (K Units)
Table 19. North America Anti-Tuberculosis Drug Sales Market Share by Country (2016-2021)
Table 20. North America Anti-Tuberculosis Drug Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Anti-Tuberculosis Drug Revenue Market Share by Country (2016-2021)
Table 22. Europe Anti-Tuberculosis Drug Sales by Country (2016-2021) & (K Units)
Table 23. Europe Anti-Tuberculosis Drug Sales Market Share by Country (2016-2021)
Table 24. Europe Anti-Tuberculosis Drug Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Anti-Tuberculosis Drug Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Anti-Tuberculosis Drug Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Anti-Tuberculosis Drug Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Anti-Tuberculosis Drug Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Anti-Tuberculosis Drug Revenue Market Share by Region (2016-2021)
Table 30. Latin America Anti-Tuberculosis Drug Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Anti-Tuberculosis Drug Sales Market Share by Country (2016-2021)
Table 32. Latin America Anti-Tuberculosis Drug Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Anti-Tuberculosis Drug Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Anti-Tuberculosis Drug Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Anti-Tuberculosis Drug Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Anti-Tuberculosis Drug Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Anti-Tuberculosis Drug Revenue Market Share by Country (2016-2021)
Table 38. Global Anti-Tuberculosis Drug Sales (K Units) by Type (2016-2021)
Table 39. Global Anti-Tuberculosis Drug Sales Market Share by Type (2016-2021)
Table 40. Global Anti-Tuberculosis Drug Revenue (Million US$) by Type (2016-2021)
Table 41. Global Anti-Tuberculosis Drug Revenue Share by Type (2016-2021)
Table 42. Global Anti-Tuberculosis Drug Price (US$/Unit) by Type (2016-2021)
Table 43. Global Anti-Tuberculosis Drug Sales (K Units) by Application (2016-2021)
Table 44. Global Anti-Tuberculosis Drug Sales Market Share by Application (2016-2021)
Table 45. Global Anti-Tuberculosis Drug Revenue (Million US$) by Application (2016-2021)
Table 46. Global Anti-Tuberculosis Drug Revenue Share by Application (2016-2021)
Table 47. Global Anti-Tuberculosis Drug Price (US$/Unit) by Application (2016-2021)
Table 48. Lupin Corporation Information
Table 49. Lupin Description and Business Overview
Table 50. Lupin Anti-Tuberculosis Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Lupin Anti-Tuberculosis Drug Product
Table 52. Lupin Recent Developments/Updates
Table 53. Otsuka Corporation Information
Table 54. Otsuka Description and Business Overview
Table 55. Otsuka Anti-Tuberculosis Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Otsuka Anti-Tuberculosis Drug Product
Table 57. Otsuka Recent Developments/Updates
Table 58. Sanofi Corporation Information
Table 59. Sanofi Description and Business Overview
Table 60. Sanofi Anti-Tuberculosis Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Sanofi Anti-Tuberculosis Drug Product
Table 62. Sanofi Recent Developments/Updates
Table 63. Prizer Corporation Information
Table 64. Prizer Description and Business Overview
Table 65. Prizer Anti-Tuberculosis Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Prizer Anti-Tuberculosis Drug Product
Table 67. Prizer Recent Developments/Updates
Table 68. Abbott Corporation Information
Table 69. Abbott Description and Business Overview
Table 70. Abbott Anti-Tuberculosis Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Abbott Anti-Tuberculosis Drug Product
Table 72. Abbott Recent Developments/Updates
Table 73. NOVARTIS Corporation Information
Table 74. NOVARTIS Description and Business Overview
Table 75. NOVARTIS Anti-Tuberculosis Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. NOVARTIS Anti-Tuberculosis Drug Product
Table 77. NOVARTIS Recent Developments/Updates
Table 78. Production Base and Market Concentration Rate of Raw Material
Table 79. Key Suppliers of Raw Materials
Table 80. Anti-Tuberculosis Drug Distributors List
Table 81. Anti-Tuberculosis Drug Customers List
Table 82. Anti-Tuberculosis Drug Market Trends
Table 83. Anti-Tuberculosis Drug Growth Drivers
Table 84. Anti-Tuberculosis Drug Market Restraints
Table 85. Global Anti-Tuberculosis Drug Sales Forecast by Type (2022-2027) & (K Units)
Table 86. Global Anti-Tuberculosis Drug Sales Market Share Forecast by Type (2022-2027)
Table 87. Global Anti-Tuberculosis Drug Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 88. Global Anti-Tuberculosis Drug Revenue Market Share Forecast by Type (2022-2027)
Table 89. Global Anti-Tuberculosis Drug Sales Forecast by Application (2022-2027) & (K Units)
Table 90. Global Anti-Tuberculosis Drug Sales Market Share Forecast by Application (2022-2027)
Table 91. Global Anti-Tuberculosis Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 92. Global Anti-Tuberculosis Drug Revenue Market Share Forecast by Application (2022-2027)
Table 93. Global Anti-Tuberculosis Drug Sales Forecast by Region (2022-2027) & (K Units)
Table 94. Global Anti-Tuberculosis Drug Sales Market Share Forecast by Region (2022-2027)
Table 95. Global Anti-Tuberculosis Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 96. Global Anti-Tuberculosis Drug Revenue Market Share Forecast by Region (2022-2027)
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-Tuberculosis Drug
Figure 2. Global Anti-Tuberculosis Drug Market Share by Type in 2020 & 2027
Figure 3. First-Line Anti-Tuberculosis Drugs Product Picture
Figure 4. Second-Line Anti-Tuberculosis Drugs Product Picture
Figure 5. Global Anti-Tuberculosis Drug Market Share by Application in 2020 & 2027
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Others
Figure 9. Global Anti-Tuberculosis Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Anti-Tuberculosis Drug Market Size 2016-2027 (US$ Million)
Figure 11. Global Anti-Tuberculosis Drug Sales 2016-2027 (K Units)
Figure 12. Global Anti-Tuberculosis Drug Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Anti-Tuberculosis Drug Sales Share by Manufacturers in 2020
Figure 14. Global Anti-Tuberculosis Drug Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Anti-Tuberculosis Drug Players: Market Share by Revenue in 2020
Figure 16. Anti-Tuberculosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Anti-Tuberculosis Drug Sales Market Share by Region (2016-2021)
Figure 18. Global Anti-Tuberculosis Drug Sales Market Share by Region in 2020
Figure 19. Global Anti-Tuberculosis Drug Revenue Market Share by Region (2016-2021)
Figure 20. Global Anti-Tuberculosis Drug Revenue Market Share by Region in 2020
Figure 21. United States Anti-Tuberculosis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Anti-Tuberculosis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Anti-Tuberculosis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Anti-Tuberculosis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. UK Anti-Tuberculosis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Anti-Tuberculosis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Anti-Tuberculosis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Anti-Tuberculosis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Anti-Tuberculosis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Anti-Tuberculosis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Anti-Tuberculosis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Anti-Tuberculosis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Anti-Tuberculosis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Anti-Tuberculosis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Anti-Tuberculosis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Anti-Tuberculosis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Anti-Tuberculosis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Anti-Tuberculosis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Anti-Tuberculosis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Anti-Tuberculosis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Anti-Tuberculosis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Anti-Tuberculosis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Anti-Tuberculosis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Anti-Tuberculosis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Anti-Tuberculosis Drug by Type (2016-2021)
Figure 46. Sales Market Share of Anti-Tuberculosis Drug by Application (2016-2021)
Figure 47. Sales Market Share of Anti-Tuberculosis Drug by Application in 2020
Figure 48. Revenue Share of Anti-Tuberculosis Drug by Application (2016-2021)
Figure 49. Revenue Share of Anti-Tuberculosis Drug by Application in 2020
Figure 50. Manufacturing Cost Structure of Anti-Tuberculosis Drug
Figure 51. Manufacturing Process Analysis of Anti-Tuberculosis Drug
Figure 52. Anti-Tuberculosis Drug Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed